Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients

British Journal of Anaesthesia

Volumn 106, Issue 6, 2011, Pages 823-826

  Suzuki, T ^a   Kitajima, O ^a   Ueda, K ^a   Kondo, Y ^a   Kato, J ^a   Ogawa, S ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

age factors; monitoring, neuromuscular function; neuromuscular block, antagonism; neuromuscular block, rocuronium; sugammadex

Indexed keywords

REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

ADDUCTOR POLLICIS; ADULT; AGE DISTRIBUTION; AGED; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; FEMALE; GYNECOLOGIC SURGERY; HAND MUSCLE; HUMAN; LARYNGEAL MASK; MUSCLE CONTRACTION; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; ULNAR NERVE;

EID: 79957519704     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer098     Document Type: Article

References (28)

1. Bevan JC, Collins L, Fowler C, et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesth Analg 1999; 89: 333-9 (Pubitemid 29367712)
2. Caldwell JE, Robertson EN, Baird WL. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium. Br J Anaesth 1986; 58: 1285-9 (Pubitemid 17178919)
3. Magorian TT, Lynam DP, Caldwell JE, Miller RD. Can early administrationof neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? Anesthesiology 1990; 73: 410-4 (Pubitemid 20298144)
4. Beemer GH, Goonetilleke PH, Bjorksten AR. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery. Anesthesiology 1995; 82: 852-8
5. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002; 96: 45-50 (Pubitemid 34032480)
6. Kopman AF, Eikermann M. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia 2009; 64 (Suppl. 1): 22-30
7. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Bülow K. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block. J Clin Anesth 1995; 7: 635-9 (Pubitemid 26011239)
8. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-70
9. Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104: 667-74
10. Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drugs, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104: 555-62
11. Pühringer FK, Rex C, Sielenkämper AW, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008; 109: 188-97
12. Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth 2010; 105: 558-67
13. Epemolu O, Bom A, Hope F, Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003; 99: 632-7 (Pubitemid 37051978)
14. Priebe HJ. The aged cardiovascular risk patients. Br J Anaesth 2000; 85: 763-8
15. Dinenno FA, Seals DR, DeSouza CA, Tanaka H. Age-related decreases in basal limb blood flow in humans: time course, determinants and habitual exercise effects. J Physiol 2001; 531: 573-9 (Pubitemid 32229680)
16. McDonagh DL, Benedict PE, Kovac AL, et al. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuroniuminduced neuromuscular blockade in elderly patients. Anesthesiology 2011; 114: 318-29
17. Suzuki T, Fukano N, Kitajima O, Saeki S, Ogawa S. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block. Br J Anaesth 2006; 96: 44-7 (Pubitemid 43124529)
18. Howardy-Hansen P, Viby-Mogensen J, Gottschau A, Skovgaard LT, Chrmmer-Jørgensen B, Engbk J. Tactile evaluation of the posttetanic count (PTC). Anesthesiology 1984; 60: 372-4 (Pubitemid 14172420)
19. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology 2004; 100: 1119-24 (Pubitemid 38541966)
20. Duvaldestin P, Kuizenga K, Saldien V, et al. A randomized, dose- response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Anesth Analg 2010; 110: 74-82
21. Werba A, Klezl M, Schramm W, et al. The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia 1993; 48: 301-3 (Pubitemid 23135509)
22. Schultz P, Ibsen M, Østergaard D, Skovgaard LT. Onset and duration of action of rocuronium-from tracheal intubation, through intense block to complete recovery. Acta Anaesthesiol Scand 2001; 45: 612-7 (Pubitemid 32417474)
23. Dwyer R, Howe J. Peripheral blood flow in the elderly during inhalational anaesthesia. Acta Anaesthesiol Scand 1995; 39: 939-44
24. Gentry-Smetana S, Redford D, Moore D, Larson DF. Direct effects of volatile anesthetics on cardiac function. Perfusion 2008; 23: 43-7
25. Suzuki T, Munakata K, Watanabe N, Katsumata N, Saeki S, Ogawa S. Augmentation of vecuronium-induced neuromuscular block during sevoflurane anaesthesia: comparison with balanced anaesthesia using propofol or midazolam. Br J Anaesth 1999; 83: 485-7 (Pubitemid 29412711)
26. Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104: 563-8
27. Rex C, Wagner S, Spies C, et al. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Anesthesiology 2009; 111: 30-5
28. Pühringer FK, Gordon M, Demeyer I, et al. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. Br J Anaesth 2010; 105: 610-19